---
title: "Kyverna Therapeutics (KYTX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/KYTX.US/norm.md"
symbol: "KYTX.US"
name: "Kyverna Therapeutics"
parent: "https://longbridge.com/zh-HK/quote/KYTX.US.md"
datetime: "2026-05-21T10:17:51.409Z"
locales:
  - [en](https://longbridge.com/en/quote/KYTX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KYTX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KYTX.US/norm.md)
---

# Kyverna Therapeutics (KYTX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.6600 | -0.8017 | -0.8473 | -0.9735 | -1.03 |
| ROE | -74.28% | -78.71% | -87.50% | -82.43% | -72.78% |
| 營業收入 | - | - | - | - | - |
| 凈利潤 | -39.73M | -37.80M | -36.79M | -42.08M | -44.63M |
| 營業利潤 | -41.37M | -39.28M | -38.73M | -44.41M | -47.41M |
| 毛利率 | - | - | - | - | - |
| 凈利率 | - | - | - | - | - |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 257.02M | 293.83M | 187.16M | 226.51M | 260.65M |
| 權益乘數 | 1.31 | 1.26 | 1.23 | 1.23 | 1.16 |
| 每股凈資產 | 3.23 | 3.85 | 3.47 | 4.26 | 5.18 |
| 資產周轉率 | - | - | - | - | - |
| 現金及短投 | 236.45M | 279.25M | 171.14M | 211.68M | 242.65M |
| 存貨與應收 | - | - | - | - | - |
| 長期投資 | 9.73M | 5.42M | 6.32M | 7.58M | 8.80M |
| 凈債務 | -202.69M | -250.22M | -166.11M | -205.76M | -235.71M |

## 現金流量表 (USD)

| 指標 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -41.60M | -33.53M | -43.32M | -31.95M | -44.91M |
| 投資現金流 | -50.20M | -17.29M | 22.56M | 29.17M | 5.58M |
| 融資現金流 | -101000.00 | 140.74M | 1.49M | -649000.00 | -414000.00 |
| 自由現金流 | -28.74M | -19.60M | -28.65M | -16.07M | -27.46M |
| 現金流充裕率 | -48368.60% | -39913.10% | -35509.02% | -12010.90% | -13171.55% |
| 舉債與償債 | - | 24.70M | - | - | - |
| 資本支出 | - | 1000.00 | -2000.00 | -4000.00 | - |